Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Burning Rock Biotech Ltd (BNR)

  • Business News
  • Jan. 05, 2026, 06:16 UTC
  • 5
  • 1 comments

Burning Rock Announces Founder’s Purchase of Its ADSs

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 05, 2026, 01:47 UTC
  • 6
  • 1 comments

Best Gaming Computers In 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 05, 2026, 01:45 UTC
  • 6
  • 1 comments

Best Gaming Desk Setup Ideas for 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 05, 2026, 01:44 UTC
  • 6
  • 1 comments

Best Guns in Warzone Right Now

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 05, 2026, 01:43 UTC
  • 5
  • 1 comments

Best Warzone Loadouts (2026)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 05, 2026, 01:43 UTC
  • 5
  • 1 comments

Best VR Headset for PC in 2026

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Jan. 05, 2026, 00:08 UTC
  • 2
  • 1 comments

[Press Release] HUTCHMED Initiates Phase III Stage of the Surufatinib plus Camrelizumab Trial in Treatment-Naïve Pancreatic Ductal Adenocarcinoma

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Jan. 05, 2026, 00:00 UTC
  • 2
  • 1 comments

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

Market reaction Comment Full text

agilon health Inc (AGL)

  • Business News
  • Jan. 04, 2026, 21:26 UTC
  • 8
  • 1 comments

AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Crinetics Pharmaceuticals Inc (CRNX)

  • Business News
  • Jan. 04, 2026, 21:00 UTC
  • 8
  • 1 comments

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

Market reaction Comment Full text
  • Previous
  • 185
  • 186
  • 187
  • 188
  • 189
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2258)
  • SEC News(189204)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124560)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin